GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis

Published:2018-10-18 Issue:1 Volume:35 Page:e3082
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Castellana Marco¹^ORCID,Cignarelli Angelo¹^ORCID,Brescia Francesco¹,Laviola Luigi¹^ORCID,Giorgino Francesco¹^ORCID

Affiliation:

1. Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation; University of Bari Aldo Moro; Bari Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.3082/fullpdf

Reference36 articles.

1. World Health Organization Global report on diabetes 2016 http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1

2. Glucose control and vascular outcomes in type 2 diabetes: is the picture clear?;Giorgino;Diabetes Care,2016

3. Standard of medical care in diabetes-2018;American Diabetes Association;Diabetes Care,2018

4. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis;Palmer;JAMA,2016

5. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40);Yokoyama;BMJ Open Diabetes Res Care,2016

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association;Diabetes & Metabolism Journal;2024-07-31

2. Inpatient diabetes management;Annals of the New York Academy of Sciences;2024-07-25

3. Open questions on basal insulin therapy in T2D: a Delphi consensus;Acta Diabetologica;2024-05-20

4. Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes;Diabetology International;2024-01-08

5. Real‐world study of the concomitant use of biphasic insulin as part 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes;Diabetic Medicine;2023-12-13